465 related articles for article (PubMed ID: 15880205)
1. [Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits].
Jorge PA; Almeida EA; Ozaki MR; Jorge M; Carneiro A
Arq Bras Cardiol; 2005 Apr; 84(4):314-9. PubMed ID: 15880205
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462
[TBL] [Abstract][Full Text] [Related]
3. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
Jones P; Kafonek S; Laurora I; Hunninghake D
Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454
[TBL] [Abstract][Full Text] [Related]
4. Rapid reversal of endothelial dysfunction in hypercholesterolaemic rabbits treated with simvastatin and pravastatin.
Jorge PA; Osaki MR; de Almeida E
Clin Exp Pharmacol Physiol; 1997 Dec; 24(12):948-53. PubMed ID: 9406661
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
Plans-Rubió P
Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
[TBL] [Abstract][Full Text] [Related]
7. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects.
Puccetti L; Bruni F; Bova G; Cercignani M; Palazzuoli A; Console E; Auteri A; Pasqui AL
Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):378-87. PubMed ID: 12055702
[TBL] [Abstract][Full Text] [Related]
8. Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin.
Brown AS; Bakker-Arkema RG; Yellen L; Henley RW; Guthrie R; Campbell CF; Koren M; Woo W; McLain R; Black DM
J Am Coll Cardiol; 1998 Sep; 32(3):665-72. PubMed ID: 9741509
[TBL] [Abstract][Full Text] [Related]
9. Effects of simvastatin and pravastatin on endothelium-dependent relaxation in hypercholesterolemic rabbits.
Jorge PA; Ozaki MR; Metze K
Exp Toxicol Pathol; 1994 Dec; 46(6):465-9. PubMed ID: 7703678
[TBL] [Abstract][Full Text] [Related]
10. Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins.
Andrews TC; Ballantyne CM; Hsia JA; Kramer JH
Am J Med; 2001 Aug; 111(3):185-91. PubMed ID: 11530028
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent effect of statins on platelet function in hypercholesterolaemia.
Puccetti L; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Angori P; Auteri A; Bruni F
Eur J Clin Invest; 2002 Dec; 32(12):901-8. PubMed ID: 12534449
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a new cholesterol synthesis inhibitor, atorvastatin, in comparison with simvastatin and pravastatin, in subjects with hypercholesterolemia.
Wolffenbuttel BH; Mahla G; Muller D; Pentrup A; Black DM
Neth J Med; 1998 Apr; 52(4):131-7. PubMed ID: 9646621
[TBL] [Abstract][Full Text] [Related]
13. The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients.
Thallinger C; Urbauer E; Lackner E; Graselli U; Kostner K; Wolzt M; Joukhadar C
Int J Clin Pharmacol Ther; 2005 Dec; 43(12):551-7. PubMed ID: 16372516
[TBL] [Abstract][Full Text] [Related]
14. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin suppresses atherosclerotic progression, mediated through its inhibitory effect on endothelial dysfunction, lipid peroxidation, and macrophage deposition.
Bandoh T; Mitani H; Niihashi M; Kusumi Y; Kimura M; Ishikawa J; Totsuka T; Sakurai I; Hayashi S
J Cardiovasc Pharmacol; 2000 Jan; 35(1):136-44. PubMed ID: 10630744
[TBL] [Abstract][Full Text] [Related]
16. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed.
Prasad K
Circulation; 1999 Mar; 99(10):1355-62. PubMed ID: 10077521
[TBL] [Abstract][Full Text] [Related]
17. Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients.
Inoue T; Hayashi M; Takayanagi K; Morooka S
Atherosclerosis; 2002 Feb; 160(2):369-76. PubMed ID: 11849660
[TBL] [Abstract][Full Text] [Related]
18. Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits.
Hu MY; Li YL; Jiang CH; Liu ZQ; Qu SL; Huang YM
Nutrition; 2008 Oct; 24(10):1030-8. PubMed ID: 18585898
[TBL] [Abstract][Full Text] [Related]
19. Lowering effects of four different statins on serum triglyceride level.
Branchi A; Fiorenza AM; Rovellini A; Torri A; Muzio F; Macor S; Sommariva D
Eur J Clin Pharmacol; 1999 Sep; 55(7):499-502. PubMed ID: 10501818
[TBL] [Abstract][Full Text] [Related]
20. Improvement in the endothelium-dependent relaxation in hypercholesterolemic rabbits treated with vitamin E.
Ribeiro Jorge PA; Neyra LC; Ozaki RM; de Almeida E
Atherosclerosis; 1998 Oct; 140(2):333-9. PubMed ID: 9862276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
